Sidley Reps Allscripts In $1.3B Deal For Eclipsys
Under the terms of the deal, Eclipsys stockholders will receive 1.2 shares of Allscripts for each Eclipsys share, a 19 percent premium based on the closing price June 8.
After the merger, the companies say they will be able to offer more comprehensive services in the field of electronic medical records, helping to build a single...
Already a subscriber? Click here to login